Difference between revisions of "RHIZEN PHARMACEUTICALS AG Patent Application Trends in 2024"
Jump to navigation
Jump to search
Wikipatents (talk | contribs) (Updating RHIZEN PHARMACEUTICALS AG_Patent_Application_Trends_in_2024) |
Wikipatents (talk | contribs) (Updating RHIZEN PHARMACEUTICALS AG_Patent_Application_Trends_in_2024) |
||
| Line 5: | Line 5: | ||
[[File:RHIZEN PHARMACEUTICALS AG Top Technology Areas 2024 - Up to June 2024.png|border|800px|RHIZEN PHARMACEUTICALS AG Top Technology Areas 2024 - Up to June 2024]] | [[File:RHIZEN PHARMACEUTICALS AG Top Technology Areas 2024 - Up to June 2024.png|border|800px|RHIZEN PHARMACEUTICALS AG Top Technology Areas 2024 - Up to June 2024]] | ||
| − | * [[:Category:CPC_C07D401/14|C07D401/14]] ( | + | * [[:Category:CPC_C07D401/14|C07D401/14]] (HETEROCYCLIC COMPOUNDS (macromolecular compounds) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| − | * [[:Category:CPC_A61K31/502|A61K31/502]] ( | + | * [[:Category:CPC_A61K31/502|A61K31/502]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| − | * [[:Category:CPC_A61K45/06|A61K45/06]] ( | + | * [[:Category:CPC_A61K45/06|A61K45/06]] (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| − | * [[:Category:CPC_A61P35/00|A61P35/00]] ( | + | * [[:Category:CPC_A61P35/00|A61P35/00]] (Antineoplastic agents) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| Line 20: | Line 20: | ||
[[File:RHIZEN PHARMACEUTICALS AG Top Emerging Technology Areas 2024 - Up to June 2024.png|border|800px|RHIZEN PHARMACEUTICALS AG Top Emerging Technology Areas 2024 - Up to June 2024]] | [[File:RHIZEN PHARMACEUTICALS AG Top Emerging Technology Areas 2024 - Up to June 2024.png|border|800px|RHIZEN PHARMACEUTICALS AG Top Emerging Technology Areas 2024 - Up to June 2024]] | ||
| − | * [[:Category:CPC_A61P35/00|A61P35/00]] ( | + | * [[:Category:CPC_A61P35/00|A61P35/00]] (Antineoplastic agents) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| − | * [[:Category:CPC_A61K45/06|A61K45/06]] ( | + | * [[:Category:CPC_A61K45/06|A61K45/06]] (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| − | * [[:Category:CPC_A61K31/502|A61K31/502]] ( | + | * [[:Category:CPC_A61K31/502|A61K31/502]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
| − | * [[:Category:CPC_C07D401/14|C07D401/14]] ( | + | * [[:Category:CPC_C07D401/14|C07D401/14]] (HETEROCYCLIC COMPOUNDS (macromolecular compounds) |
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ** Example: [[20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)]] | ||
Latest revision as of 16:52, 29 July 2024
Contents
RHIZEN PHARMACEUTICALS AG Patent Filing Activity
RHIZEN PHARMACEUTICALS AG patent applications in 2024
Top 10 Technology Areas
- C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
- A61K31/502 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
- A61P35/00 (Antineoplastic agents)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
Emerging Technology Areas
- A61P35/00 (Antineoplastic agents)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
- A61K31/502 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
- C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240199582. INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE simplified abstract (RHIZEN PHARMACEUTICALS AG)
Top Inventors
- Swaroop Kumar Venkata Satya VAKKALANKA (1 patent)
- Debnath BHUNIYA (1 patent)
- Srikant VISWANADHA (1 patent)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
RHIZEN PHARMACEUTICALS AG Inventor States 2024 - Up to June 2024
